Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
11 studies found for:    e1411
Show Display Options
Rank Status Study
1 Recruiting Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma
Conditions: Lymphoma;   Neurotoxicity;   Therapy-related Toxicity
Interventions: Biological: rituximab;   Drug: bendamustine hydrochloride;   Drug: bortezomib;   Drug: lenalidomide
2 Recruiting Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients
Conditions: AML;   Adult
Intervention: Other: Observation
3 Recruiting Window of Opportunity Trial of ADXS 11-001 Vaccination Prior to Robotic Surgery of HPV-Positive Oropharyngeal Cancer
Conditions: Head and Neck Cancer;   Squamous Cell Carcinoma of the Head and Neck;   Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma
Intervention: Biological: ADXS11-001 (ADXS-HPV)
4 Recruiting Dysfunctional Hemoglobin
Condition: Elevated Levels of Carboxyhemoglobin and Methemoglobin
Intervention: Other: Elevated levels of carboxyhemoglobin
5 Completed
Has Results
Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Stroke
Interventions: Drug: warfarin;   Drug: Dabigatran dose 1;   Drug: Dabigatran dose 2
6 Completed
Has Results
Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women
Condition: Vasomotor Symptoms
Interventions: Drug: desvenlafaxine succinate (DVS) SR;   Drug: Placebo
7 Completed
Has Results
Levonorgestrel Contraceptive Intrauterine Systems (LCS) Pearl Index Study
Condition: Contraception
Interventions: Drug: LCS12;   Drug: LCS16
8 Completed
Has Results
Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.
Condition: Cardiovascular Diseases
Interventions: Drug: Telmisartan;   Drug: Combination of Telmisartan and Ramipril;   Drug: Ramipril
9 Completed To Assess the Long-term Safety, Efficacy and Tolerability of Inhaled Aclidinium Bromide in the Treatment of Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Aclidinium bromide;   Drug: Placebo
10 Completed
Has Results
Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients.
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: Tiotropium bromide;   Drug: Salmeterol;   Drug: Placebo Salmeterol;   Drug: Placebo Tiotropium
11 Recruiting BMN-673 and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies
Conditions: Adult Solid Neoplasm;   Childhood Solid Neoplasm;   Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
Interventions: Drug: PARP Inhibitor BMN-673;   Drug: Temozolomide;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study

Indicates status has not been verified in more than two years